Met and HGF inhibition in triple-negative breast cancer cell lines

被引:0
|
作者
Gaule, Patricia Brid
Collins, Denis
Walsh, Naomi
Duffy, Michael J.
Crown, John
O'Donovan, Norma
机构
[1] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland
[2] St Vincents Univ Hosp, Clin Res Ctr, Dublin 4, Ireland
[3] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland
[4] Dublin City Univ, Dublin 9, Ireland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1066
引用
收藏
页数:1
相关论文
共 50 条
  • [31] SIGNIFICANCE OF C-MET AS A THERAPEUTIC TARGET IN TRIPLE-NEGATIVE BREAST CANCER
    Kashiwagi, S.
    Yashiro, M.
    Aomatsu, N.
    Kawajiri, H.
    Takashima, T.
    Onoda, N.
    Ishikawa, T.
    Hirakawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 84 - 84
  • [32] Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines
    Pierce, Aisling
    McGowan, Patricia M.
    Cotter, Maura
    Mullooly, Maeve
    O'Donovan, Norma
    Rani, Sweta
    O'Driscoll, Lorraine
    Crown, John
    Duffy, Michael J.
    CANCER BIOLOGY & THERAPY, 2013, 14 (06) : 537 - 545
  • [33] Suppression of Invasion and Metastasis of Triple-Negative Breast Cancer Lines by Pharmacological or Genetic Inhibition of Slug Activity
    Ferrari-Amorotti, Giovanna
    Chiodoni, Claudia
    Shen, Fei
    Cattelani, Sara
    Soliera, Angela Rachele
    Manzotti, Gloria
    Grisendi, Giulia
    Dominici, Massimo
    Rivasi, Francesco
    Colombo, Mario Paolo
    Fatatis, Alessandro
    Calabretta, Bruno
    NEOPLASIA, 2014, 16 (12): : 1047 - 1058
  • [34] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
  • [35] Synergistic chemosensitivity of triple-negative breast cancer cell lines to a PARP inhibitor, cisplatin and gemcitabine
    Hastak, Kedar
    Alli, Elizabeth
    Ford, James
    CANCER RESEARCH, 2009, 69
  • [36] Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
    Fink, Lauren S.
    Beatty, Alexander
    Devarajan, Karthik
    Peri, Suraj
    Peterson, Jeffrey R.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (01) : 298 - 306
  • [37] Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines
    Jafari, Sevda
    Dabiri, Sheida
    Aghdam, Elnaz Mehdizadeh
    Fathi, Ezzatollah
    Saeedi, Nazli
    Montazersaheb, Soheila
    Farahzadi, Raheleh
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (08): : 2559 - 2568
  • [38] Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines
    Lefebvre, Cory
    Pellizzari, Sierra
    Bhat, Vasudeva
    Jurcic, Kristina
    Litchfield, David W.
    Allan, Alison L.
    BIOMEDICINES, 2023, 11 (09)
  • [39] Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines
    Sevda Jafari
    Sheida Dabiri
    Elnaz Mehdizadeh Aghdam
    Ezzatollah Fathi
    Nazli Saeedi
    Soheila Montazersaheb
    Raheleh Farahzadi
    Clinical and Translational Oncology, 2023, 25 : 2559 - 2568
  • [40] Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines
    Kundur, Sai
    Prayag, Amrita
    Selvakumar, Priyanga
    Hung Nguyen
    McKee, Lloyd
    Cruz, Clairissa
    Srinivasan, Asha
    Shoyele, Sunday
    Lakshmikuttyamma, Ashakumary
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 11103 - 11118